Eur Rev Med Pharmacol Sci 2021; 25 (3): 1616-1621
DOI: 10.26355/eurrev_202102_24872

Effects of curcumin administration on Nesfatin-1 levels in blood, brain and fat tissues of diabetic rats

S. Algul, O. Ozcelik, G. Oto, M. Sarikaya, R.T. Goceroglu, N.M. Embiyaoglu, F. Caf, S. Öner, A.G. Akcan

Department of Physiology, Van Yuzuncu Yil University, Faculty of Medicine, Van, Turkey. serminalgul@hotmail.com or


OBJECTIVE: We evaluated the efficacy of curcumin administration on blood glucose levels and its relationship with nesfatin-1 levels in blood brain and adipose tissue of streptozotocin-induced diabetic rats.

MATERIALS AND METHODS: A total of 28 male rats were divided into four groups: control group, type 2 diabetes mellitus (DM) group, control plus curcumin group and type 2DM plus curcumin group. After fifteen days, blood samples were collected from sacrificed rats. Nesftain-1 levels were analysed from blood, brain, and fat tissues of rats in all groups.

RESULTS: Nesfatin-1 level was found to be significantly lower in blood, brain and fat tissues of type 2 DM rats compared to the control group. A significant decrease in fasting blood glucose levels was observed in the curcumin administration group compared to type 2 DM group. Improvement of fasting blood glucose level was accompanied by improvement of nesfatin-1 levels in blood, brain, and fat tissues.

CONCLUSIONS: As expected, curcumin administration caused significant improvement in fasting blood glucose levels. However, for the first time, we found marked improvements in nesfatin-1 levels in blood, brain, and fat tissues of type 2 DM rats. Thus, considering the crucial role of nesfatin-1 in regulation of glucose metabolism, it is logical to expect an interactive relationship between curcumin and nesfatin-1.

 

Free PDF Download

To cite this article

S. Algul, O. Ozcelik, G. Oto, M. Sarikaya, R.T. Goceroglu, N.M. Embiyaoglu, F. Caf, S. Öner, A.G. Akcan
Effects of curcumin administration on Nesfatin-1 levels in blood, brain and fat tissues of diabetic rats

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 3
Pages: 1616-1621
DOI: 10.26355/eurrev_202102_24872